| Symbol | APUS |
|---|---|
| Name | APIMEDS PHARMACEUTICALS US, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 100 MATAWAN RD, MATAWAN, NJ 07747 |
| Telephone | 848-201-5010 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | None |
(70% Positive) APIMEDS PHARMACEUTICALS US, INC. (APUS) Reports Q2 2026 Financial Results
Read more(99% Neutral) APIMEDS PHARMACEUTICALS US, INC. (APUS) Announces Update on Collaboration with Apimeds Pharmaceuticals US
Read moreApimeds Pharmaceuticals Investor News: Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
Read moreRosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
Read moreNew Form 425 - Apimeds Pharmaceuticals US, Inc. <b>Filed:</b> 2026-04-09 <b>AccNo:</b> 0001213900-26-042030 <b>Size:</b> 47 KB
Read moreNew Form 8-K/A - Apimeds Pharmaceuticals US, Inc. <b>Filed:</b> 2026-04-09 <b>AccNo:</b> 0001213900-26-042017 <b>Size:</b> 227 KB <br />Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers <br …
Read moreNew Form NT 10-K - Apimeds Pharmaceuticals US, Inc. <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001213900-26-037575 <b>Size:</b> 20 KB
Read moreNew Form SCHEDULE 13D/A - Apimeds Pharmaceuticals US, Inc. <b>Filed:</b> 2026-03-30 <b>AccNo:</b> 0001213900-26-035996 <b>Size:</b> 18 KB
Read more(95% Neutral) APIMEDS PHARMACEUTICALS US, INC. (APUS) Announces Business Combination
Read more(99% Neutral) APIMEDS PHARMACEUTICALS US, INC. (APUS) Announces New Board Appointment
Read more